Windlas family has been in business since 2001. Our journey has been exciting and rewarding with a successful track record of different products, customers and teams.

Windlas Biotech has become one of India’s leading Generic Formulations CDMO manufacturers in a short span. We have done this with our commitment to all the stakeholders, from clients to investors. This pushes us to deliver not only high-quality products but also great profitability. Cruising along the same path, we have also had a significant impact with our Trade Generics & Institutional Business vertical, which is growing at a steady pace. With tremendous potential, this vertical will set the ground for future growth. Riding on the pillars of Scalability, Durability and Profitability, Windlas Biotech is all set to make a deep dent in the industry following our successful IPO and complete fund utilization from the same.